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ABSTRACT
DNA and RNA oligomers that contain stretches of
guanines can associate to form stable secondary
structures including G-quadruplexes. Our study
shows that the (UUAAAAGAAAAGGGGGGAU) RNA
sequence, from the human immunodeficiency virus
type 1 (HIV-1 polypurine tract or PPT sequence)
forms in vitro a stable folded structure involving the
G-run. We have investigated the ability of pyrimidine
peptide nucleic acid (PNA) oligomers targeted to the
PPT sequence to invade the folded RNA and exhibit
biological activity at the translation level in vitro
and in cells. We find that PNAs can form stable
complexes even with the structured PPT RNA target
at neutral pH. We show that T-rich PNAs, namely the
tridecamer-I PNA (C4T4CT4) forms triplex structures
whereas the C-rich tridecamer-II PNA (TC6T4CT)
likely forms a duplex with the target RNA.
Interestingly, we find that both C-rich and T-rich
PNAs arrested in vitro translation elongation
specifically at the PPT target site. Finally, we show
that T-rich and C-rich tridecamer PNAs that have
been identified as efficient and specific blockers of
translation elongation in vitro, specifically inhibit
translation in streptolysin-O permeabilized cells
where the PPT target sequence has been introduced
upstream the reporter luciferase gene.
INTRODUCTION
DNA and RNA oligomers that contain consecutive
guanine (G) nucleotides are capable of folding into
stable secondary structures such as G-quadruplexes,
wherein four Gs are hydrogen bonded together into
a roughly square planar array (1). G-quadruplexes are of
remarkable stability and have been proposed to be
involved in regulation of gene expression. For example,
a DNA G-quadruplex structure formed in the c-myc
promoter region functions as a transcriptional repressor
element and an RNA G-quadruplex is believed to regulate
alternative splicing of the pre-mRNA coding for hTERT,
the reverse transcriptase component of the enzyme
telomerase (2,3).
Human immunodeﬁciency virus type-1 (HIV-1)
contains the 50A4GA4G6A polypurine tract sequence
(PPT) that is conserved in all HIV-1 strains and is present
in the coding region of integrase (IN) and nef messenger
RNAs. G-quadruplexes have been implicated in HIV-1
RNA dimerization (4) and recently were shown to occur
in a reverse transcription intermediate, namely between
the overlapping strands of the HIV-1 central DNA
ﬂap (5). It has been shown that HIV-1 nucleocapsid
(NCp) and gp 120 envelope protein exhibit a high
aﬃnity for several tetramolecular quadruplexes (6,7).
RNA quadruplexes are more stable than their DNA
counterparts and in most cases no dissociation is
experimentally observed for G tracts involving ﬁve
guanine quartets (8).
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(PNA) targeted to the folded PPT sequence of HIV-1
messenger RNA. PNAs are DNA analogues in which the
N-(2-aminoethyl) glycine units replace the deoxyribose
phosphate backbone (9–11). PNAs are capable of
sequence speciﬁc recognition of DNA and RNA,
obeying the Watson–Crick hydrogen-bonding or/and
Hoogsteen schemes (9–11). The neutral amide backbone
of PNAs increases their binding aﬃnity to DNA and
RNA and the hybrid complexes exhibit high thermal
stability (11–14). Short PNA probes were shown to be able
to disturb and ﬁnally to bind folded RNA structures used
as target sequences (15). Here, we show that pyrimidine
PNAs overcome kinetic and thermodynamic obstacles and
succeed to hybridize to folded PPT sequence and ﬁnally
to unfold it. We have examined whether complexes
formed with PNAs on the PPT sequence, likely triplex
and duplex structures, aﬀect RNA translation elongation
in vitro. The cellular antisense activity of the best
inhibitors in vitro was tested in streptolysin-O (SLO)
permeabilized cells stably transformed with two reporter
genes, the ﬁreﬂy luciferase (luc) and GFP that contain
upstream of the reporter genes either the wild-type HIV-1
PPT target sequence, or a mutated HIV-2 PPT sequence,
respectively.
MATERIAL AND METHODS
Oligonucleotides
The DNA, RNA and PNA oligonucleotides presented
here were synthesized by Eurogentec (Seraing, Belgium).
13-mer-Acr PNA was synthesized as previously described
(16). Sequences and names are given in Table 1. The
oligoribonucleotides (RNA) were 50 end-labelled with
[g
32P] ATP (3000Ci/mmol) and 10 units of T4 poly-
nucleotide kinase.
Spectroscopic experiments
Association and dissociation of the diﬀerent PNA–RNA
complexes were estimated by cooling/heating experiments,
recording the UV absorbance as a function of temperature
on Uvikon XL spectrophotometer (BioTek) with 1cm
optical pathlength quartz cuvettes. The temperature of cell
holder was regulated by a Peltier thermosystem driven by
LifePower tm software (DuSoTec GmbH) for the control
and data acquisition. Samples were ﬁrst heated to 958C,
then cooled down to 208C and heated to 858C at the rate
of 0.58C/min or 0.18C/min with absorbance readings
taken every 18C at 260 and 400nm. Samples were
prepared in a buﬀer containing 100mM KCl and 10mM
sodium cacodylate, pH 7. For cooling-melting tempera-
ture analysis, the baseline drift was corrected by
subtracting absorbance at 400nm from that at 260nm.
The cooling–melting curves were obtained by plotting
the corrected absorbance at 260nm versus temperature.
The maximum of the ﬁrst derivative of the cooling–
melting curves (@A/@T) was taken as an estimation of Tass
or Tdis values. The Tass and Tdis were estimated within,
 18C accuracy.
Electrophoretic mobility shiftassay
Unless otherwise indicated, the standard buﬀer (10ml)
for the PNA-binding assay contained 2 nM of 50-end
labelled RNAs in 50mM Tris, pH 8. Samples were
incubated with increasing concentrations of PNA at 258C
for 10min. Gel electrophoresis was run at 258C on a 15%
polyacrylamide/bisacrylamide (19/1) non-denaturing
gel or 12% polyacrylamide/7M urea denaturing gel.
The gel and buﬀer contained TBE (100mM Tris/90mM
Boric acid/1mM EDTA) at pH 8.3. Following
autoradiography a PhosphorImager was used for
quantitation.
Table 1. Oligoribonucleotides and PNA used in this study
A: Oligoribonucleotides used as PNA binding target for thermal denaturation experiments
RNA-I-wt: 50AAAAGAAAAGGGG30
RNA-I-mut: 50AAAAGAAAAAGGA30
RNA-II-wt: 50AGAAAAGGGGGGA30
RNA-II-mut: 50AGAAAAAGAGAGA30
B: Oligoribonucleotides used as PNA binding target for gel shift assays
RNA-III-wt: 50UUAAAAGAAAAGGGGGGAU30
RNA-III-mut: 50AUAAAAGAAAAAGGAGGAU30
C: PNA
as used in this study
13mer-I PNA: NH2-CCCCTTTTCTTTT-Lys
13mer-II PNA: NH2-TCCCCCCTTTTCT-Lys
13mer-I-Acr PNA: Acr-eg1-CCCCTTTTCTTTT-Lys
b
9mer PNA: NH2-TTTTCTTTT-Lys
9mer-Acr PNA: Acr-AEEA-TTTTCTTTT-Lys
c
9mer-bis-PNA: NH2-TTTTCTTTT-AEEA-TTTTCTTTT-Lys
c
11mer-bis-PNA: NH2-CCTTTTCTTTT-AEEA-TTTTCTTTTCC-Lys
c
13mer-scr PNA: NH2-TTTTCCTCTCCCT-Lys
D: ODNs used for RNAse H cleavage
15mer-PPT: 50 TCTTTTAAAATTGTG30
15mer-PPT-I: 50 AATTTTCTTTAATTC30
15mer-PPT-II: 50 TTATTCTTTAGTTTG30
aPNA base sequences are written from N to C terminus.
beg1, 8-amino-3, 6 dioxaoctanoic acid.
cAEEA, 2-(2aminoethoxy) ethoxy acetic acid.
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The plasmid pRP159 (gift from Dr D. van Gent,
Netherlands Cancer Institute, Amsterdam) was con-
structed by insertion of HIV-1 integrase gene ( 0.9kb),
into the pSP65 host vector (Promega) behind the SP6
promoter. In vitro transcription was performed on Nde-I
linearized pRP159 using standard conditions (RiboScribe
SP6 RNA Probe Synthesis Kit, Epicentre Technologies).
The transcripts were translated in rabbit reticulocyte
lysate purchased from Promega. Lysate (17ml) was
added to the reaction mixture (25ml) supplemented with
amino acid mix (1ml, without methionine),
35S methionine
(1ml, 15mCi/ml), PNA and transcript. The reaction
mixture was incubated for 20min at 378C and 8mlo f
the mixture was analysed on a 14% (w/v) Tris–Glycine,
SDS–PAGE, NOVEX
TM pre-cast gel (Invitrogen).
Translation kinetics experiments were carried out in the
same reaction mixture. Aliquots (10ml) were removed at
the indicated times and quenched by addition of an equal
volume of 2-fold concentrated loading buﬀer supplemen-
ted with b mercaptoethanol. Protein was quantitated using
a Molecular Dynamics PhosphorImager.
Cell cultures
The CMV (þ) PPT/HeLa cells stably contain two reporter
genes, the ﬁreﬂy luciferase (Photinus pyralis) gene (luc) and
the GFP gene, under the control of a bi-directional
doxycycline-inducible CMV promoter. These cells contain
the PPT sequence (50AAAAGAAAAGGGGGGA) or
a mutated sequence (50 AAAAGAAGGGGAGGAA)
upstream of the AUG translation start site of luciferase
and GFP genes respectively (17). The CMV-luc/HeLa
cells contain the reporter gene (luc) under the control
of a doxycycline-inducible CMV promoter. There is no
insertion of the PPT containing fragment in these cells.
Both cell lines were grown in DMEM (Invitrogen)
supplemented with 10% of fetal bovine serum, 2mM
glutamine, 50U/ml of penicillin and 50mg/ml of strepto-
mycin. Cell culture medium was supplemented with G418
(500mg/ml) and puromicin (2.5mg/ml) to maintain the
integrated target sequences.
Reversible permeabilization andluciferase assay
SLO (Institute of Medical Microbiology and Hygiene,
Mainz, Germany) was used to reversibly permeabilize
CMV/(þ)PPT/HeLa or CMV-luc/HeLa cell lines toward
PNAs according to a recently revised protocol (17–18).
SLO was conserved in PBS buﬀer supplemented with
0.1% BSA. Cells were washed twice and re-suspended in
HBSS (Hanks’ balanced salt solution with calcium and
magnesium, 10mM HEPES, and 1% fetal bovine serum).
For each experiment, in a 48-well dishes, 1.3 10
5 cells in
100ml were permeabilized by addition of an optimized
amount of SLO (110ng) and then incubated at 378C for
15min, in the presence of PNAs. Resealing was achieved
by addition of 800ml of DMEM supplemented with 10%
fetal calf serum and further incubation at 378C for 20min.
Cells were then transferred in 96-well dishes (4 10
4cells/
well) and cultured at 378C for 4h and then induced by
addition of doxycycline (Sigma) and further cultured 40h
before quantifying ﬁreﬂy luciferase activity, GFP and total
proteins. In the same time, cells were examined with
respect to permeabilization eﬃciency and viability by ﬂow
cytometry (Facsort, Beckton Dickinson). Brieﬂy, during
permeabilization PNAs were replaced with FITC (20mM)
and after resealing cells were washed twice with PBS and
passed through ﬂow cytometer in PBS supplemented with
propidium iodide (10mg/ml) which permitted to determine
the fraction of permeabilized and viable cells in the
original culture. At the end of experiment, cells were
harvested for lysate (passive lysis buﬀer, Promega) and
both the ﬁreﬂy luciferase activity [expressed in relative
light units (RLU)], GFP ﬂuorescence and protein
concentration [Bradford reagent from Bio-Rad, expressed
in optical density (OD)] were measured using a spectro-
ﬂuorimeter (Wallac Victor 2 Multi-label Counter, Perkin
Elmer). The luciferase activity and GFP expression shown
in Figure 6 were normalized to the absorbance data, that
reﬂect the amount of proteins, and then expressed as
a percentage compared with the luciferase activity and
GFP ﬂuorescence levels that were obtained in SLO-treated
cells in the absence of PNA. Each data point was averaged
over two replicates of three separate experiments.
RESULTS AND DISCUSSION
RNA targetcharacterization
Figure 1 shows the electrophoretic mobility of the 19-mer,
RNA-III-wt oligoribonucleotide containing the PPT
sequence of the HIV-1 integrase coding sequence
(Table 1). Several slow migrating species are detected
with wild-type RNA (lane 1), while the derived 19-mer
mutated RNA, RNA-III-mut, in which two adenines
break the G-tract migrates faster and as a single species
(lane 2). Such observations supports the involvement of
the G-run in the structure of the RNA PPT sequence that
likely adopts a quadruplex form. Indeed, stretches of
guanines can associate through hydrogen bonding to
form four-stranded structures. G-quadruplexes are of
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Figure 1. RNA-III-wt is a 19-mer oligoribonucleotide that contains a
G6 tract (lane 1). Two adenines break the G6 tract in RNA-III-mut
oligomer (lane 2) (see Table 1 for sequences). (A)
32P-radiolabelled
RNA-III-mut (1mM) was incubated with the indicated amounts of
NaOH for 15min at 258C and loaded on a 15% polyacrylamide gel.
(B) Denaturation of RNA-III-wt by NaOH was quantiﬁed by
PhosphorImager analysis.
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monovalent cations (typically K
þ or Na
þ) that exhibit
a suitable size for interaction with the electronegative
carbonyl oxygen ring inside the G-quartet (19–21).
Recently, Mergny et al. (20) have shown that the RNA
sequence r-UG4U, forms extremely stable parallel
RNA quadruplex that is much more stable than its
DNA counterpart. The increased stability of RNA
quadruplexes results from a faster association and a
slower dissociation. Strand concentration and ionic
environment plays an important role in the kinetics of
quadruplex formation. In our case, the folded RNA
structure was observed at very low 19-mer RNA-III-wt
concentrations (2 nM) in the absence of added mono-
valent ions. One explanation is that this 19-mer RNA
sequence is already folded after the synthesis and that
during sample drying, setting in solution and dilution, the
folded structure is maintained. This is not astonishing
insofar as the lifetime of r-UG4U quadruplex at 378C was
estimated to be more than 100 years (20). The multiple
bands of RNA-III-wt can be assessed to folded structures
isomers. We have used in our studies diﬀerent batches
of synthesis and always observed the same proﬁle of
migration. NaOH addition to the RNA-III-wt showed
a shift of the folded structures to an unfolded structure,
which migrated at the same position as mutated
RNA-III-mut (Figure 1A). Folded structures titration
by NaOH allowed the determination of a mid-point
transition from structured-RNA-III-wt to RNA-III-wt
monomer at 9mM NaOH (Figure 1B).
Invasionof PPTRNA structure bycomplementary PNAs
Native gel-shift experiments. In order to determine
whether short complementary PNAs can invade and
bind to structured RNA targets, here RNA-III-wt, we
have used electrophoretic mobility shift assays. Binding
of PNAs to unfolded RNA-III-mut was also analysed.
32P-radiolabelled RNAs were incubated in the absence or
in the presence of increasing concentrations of tridecamer
PNAs, 13-mer-I and 13-mer-II. Figure 2A shows that at
low concentrations (525 nM) tridecamers form complexes
that migrate slower than folded RNA [complex (s)] while
at higher concentrations a discrete, faster migrating
complexes [complex (f)] were predominant. We postulated
that retarded low mobility species result from the ﬁxation
of PNAs to the A-rich region of the target sequence not
engaged in the structure formed by the G-tract while
high mobility complexes result from the invasion of RNA
structures by 13-mer-I and 13-mer-II PNAs.13-mer-II
PNA that can form six C.G base pairs invades slightly
more eﬃciently folded RNA than 13-mer-I PNA that
can form only four C.G base pairs with the PPT RNA
target. The binding of the two tridecamer PNAs was also
studied on the mutated target, RNA-III-mut. This RNA
sequence is not stably structured and is complementary
on 11 and 8 contiguous nucleotides with 13-mer-I
and 13-mer-II PNAs, respectively. Then, binding of
13-mer-PNAs can be also observed on this RNA
sequence, with complexes migrating at the same position
as the ones observed on the wild-type sequence after
PNA-induced unfolding (Figure 2A). Binding eﬃciencies
of 13-mer-PNAs on the two RNA targets, wild type and
mutated, was measured. For tridecamer-PNAs complexed
to RNA-III-wt, we could not determine precisely the K50
values (that means the concentrations of PNAs required
for the formation of 50% of complex) because of the
multiplicity of the slow-mobility complexes, however these
values are situated between 2 and 5 nM. On the contrary,
K50 values can be determined on unstructured RNA-III
mut; for unmodiﬁed and acridine-modiﬁed tridecamer-
PNAs complexed to RNA-III-mut, K50 was determined
around 4 nM.
To further characterize PNA binding to the folded
PPT RNA sequence we used truncated PNA sequences,
9-mer and 11-mer. They are complementary both to the
wild-type and the mutated sequence, to the A-rich region
that is not involved in the structure of the PPT RNA. The
9-mer and 11-mer sequences were also used as bis-PNAs
(see Table 1 for sequences), that were expected to bind
eﬃciently to the PPT sequence. As expected, these short
sequences bind to folded RNA-III-wt sequence and no
unfolding was observed even at high PNA concentrations
(Figure 2A), consistent with the fact that the target
sequence is not involved in the structure. The 9-mer and
9-mer-bis PNAs, bind very eﬃciently to the wild-type
and mutated RNA sequences. K50 values are situated in
the range of 2–4nM. On the mutated RNA target, the
complexes are well resolved; with the monomeric PNA
9-mer an unique complex is observed whereas with both
bis-PNAs, 9-mer and 11-mer-bis PNAs, two discrete
shifted complexes (Figure 2A, C1 and C2) were observed.
In the case of 11-mer-bis PNA, there are two bands
in complex C1. Probably, 11-mer-bis PNA forms with
RNA-III-wt two structurally isomeric C1 complexes.
Similar structurally isomeric complexes formed between
homopyrimidine bis-PNAs and single- and double-
stranded DNA targets have been reported (22). At low
bis-PNA concentrations, complex C1 was predominant
while at high concentrations complex C2 was predomi-
nant. The complex C1 formed with 9-mer bis-PNA
migrates as complex formed with 9-mer PNA and
corresponds to the triplex formed with the A4GA4
purine sequence with two 9-mer PNAs. Complex C2 can
be assigned to the triplex formation with two bis-PNAs as
illustrated in Figure 2A. If it was the case, this complex
would contain two free PNA strands that could form
a PNA–RNA–PNA triplex with another RNA target.
Indeed, upon addition of an excess of 19-mer RNA super-
shifted complexes have been obtained with 9-mer bis-PNA
and 11-mer bis-PNA (Figure 2B). Figure 2B shows that in
the presence of 400nM PNAs, almost the totality of the
RNA-III-wt was converted in slow migrating (s) and fast
migrating (f) complexes depending on PNA sequences.
Upon addition of an excess RNA-III no change in the
migration of complexes were observed except for
complexes formed with 11-mer-bis and 9-mer-bis PNAs
that were super-shifted (Figure 2B). These results support
a model where each bis-PNA molecule participates in
the triplex structure with only one arm; the second arm
of each bis-PNA remains free (Figure 2A, complex C2).
It is noteworthy that the lifetimes of complexes formed
3910 Nucleic Acids Research, 2007, Vol. 35, No. 12C2
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Figure 2. (A) Gel mobility-shift analysis of PNAs binding to their target RNA. A ﬁxed concentration of the
32P-labeled RNA-III-wt and mismatches
containing RNA-III-mut (2 10
 9M) were incubated in 50mM Tris (pH 8) buﬀer with increasing concentration of PNA as indicated above the
lanes. Slow migrating complexes (s) correspond to the complexes formed with folded RNA whereas higher electrophoretic mobility complexes (f)
correspond to the invasion complexes that unfold the structured RNA target. C1 and C2 denote complexes involving one and two molecules of bis-
PNAs respectively. (B) An excess of the RNA target sequence (2.5-fold excess relative to PNA concentration (400 nM)) was added to the complexes
and incubated for 5min. Bound and unbound complexes were separated in a 15% non-denaturing polyacrylamide gel at 208C. RNA-III-wt (top) and
RNA-III-mut (bottom) were used as targets.
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RNA-III-mut as upon addition of an excess of target
RNA followed by 5min of incubation, partial dissociation
of PNA–RNA-III-mut complexes was observed, whereas
PNA–RNA-III-wt complexes were not dissociated
(Figure 2B).
PNA2–RNA triplexes resist to denaturing gel
conditions. In order to explore the stability of folded
RNA and of its complexes with diﬀerent PNAs we loaded
the samples on denaturing acrylamide (7M urea) gel.
Figure 3 shows that wild-type RNA structures and
complexes with PNA resist to the denaturing conditions.
Complexes formed with mutated RNA are less stable
in these conditions since complete shift of RNA was
not achieved at the concentrations observed in non-
denaturing gel.
The cooling/melting temperatures of complexes formed on
PPT RNA sequence with different PNAs. UV-melting
curves were performed to further characterize the diﬀerent
complexes. For the two PNA tridecamers, 13-mer-I and
13-mer-II, the melting proﬁles are very diﬀerent
(Figure 4); the heating and cooling curves are super-
imposed for the 13-mer-II in contrast to that is observed
for the 13-mer-I. In the latter case, temperatures of
dissociation and association depend on the heating rate,
supporting non-equilibrium conditions during experiment
which gave rise to hysteresis phenomenon. This observa-
tion is consistent with duplex formation with 13-mer-II
PNA and triplex formation with 13-mer-I PNA since
triplex formation is known to be slower than duplex one
(23). At acidic pH the melting curves of 13-mer-II PNA
were similar to those obtained at neutral pH, suggesting
that cytosine protonation is not involved in complex
stability as expected for triplexes formed with C-rich
third strand (data not shown). Altogether, these results
suggest that tridecamer PNAs form at neutral pH
stable complexes involving duplex (13-mer-II) or triplex
(13-mer-I). To better characterize the complex formed
with the 13-mer-I PNA on the PPT RNA, melting proﬁles
were performed with the 9-mer PNA that forms a triplex
on the A4GA4 sequence. In the models proposed
for triplex formation with T-rich PNAs, Tass reﬂects the
non-equilibrium formation of triplex while Tdis reﬂects in
most cases the duplex dissociation (24). Our experiments
are consistent with this model; Tdis values were almost the
same (Tdiss (9-mer)¼848C and Tdis (13-mer-I)¼888C)
but Tass are completely diﬀerent (Tass (9-mer)¼588C and
Tass (13-mer-I)¼708C).
Finally, triplex and duplex-forming tridecamer PNAs
discriminate wild-type target from mutated one.
An important decrease on Tass (between 78C and 128C)
of 13-mer-I, 13-mer-I-Acr and 13-mer-II PNAs to RNA-
I-mut compared with RNA-I-wt was observed (Table 2).
PNA–RNA complexes arrest translation elongation
in vitro andinduce synthesis of truncated proteins
As expected, 13-mer-I PNA that forms a triplex with PPT
sequence inhibits translation of HIV-1 integrase coding
mRNA in vitro in a dose-dependent manner (Figure 5A).
This inhibition is accompanied by the synthesis of a
truncated protein. The truncated protein size (18kDa)
is similar to the size of the polypeptide chain obtained
after RNase H cleavage of the RNA duplexed to a 15-mer
phosphodiester oligonucleotide targeted to the PPT region
(15-mer-PPT) (Figure 5A, lane 8). Interestingly, 13-mer-II
PNA that forms a duplex with the PPT sequence is as
eﬃcient as 13-mer-I PNA to arrest translation elongation
(Figure 5A). We have determined an IC50 value of 0.3mM
and 0.2mM for PNA 13-mer-I and 13-mer-II, respectively.
Both tridecamer PNAs did not aﬀect the translation
of Ha-ras and Pyralis Luciferase messenger RNAs
(Figure 5A for 13-mer-II and data not shown for
13-mer-I).
The time course for translation elongation arrest at
a ﬁxed PNA 13-mer-I concentration was also examined
(Figure 5B). In the absence of PNA, translation full-
length protein (p32, IN) synthesis was achieved in 4min.
In the presence of 13-mer-I PNA, the truncated p18
polypeptide was detected as early as 2min after the
initiation of translation. Truncated protein life-time is
signiﬁcantly higher when translation elongation was
arrested with 13-mer-I PNA compared with 13-mer-II
PNA: Figure 5B shows that depending on the PNA
concentration used, the amount of truncated protein
dropped to 80, 60 and 30% after 20min of translation
in the presence of 13-mer-I PNA whereas lower quantities
(60, 40 and 20%) were obtained in the presence of
13-mer-II PNA. These results may reﬂect the longer
lifetime of PNA2-RNA complexes versus the PNA–RNA
complexes. These PNAs, 13-mer-I, 9-mer, 9-mer-bis,
11-mer-bis, share in common the T4CT4 sequence. HIV
integrase coding mRNA contains a A3GA3 and A3GA2
sequences situated respectively upstream and downstream
of the PPT sequence (25). Figure 5C shows that high
concentrations of 13-mer-I PNA (40.4mM) arrest
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Figure 3. The
32P-labelled RNA-III-wt and RNA-III-mut were
incubated in 50mM Tris (pH 8) buﬀer with increasing concentration
of PNA (50, 200 and 400 nM) and loaded on a 15% polyacrylamide,
7M urea gel. Arrows indicate the migration position of wild-type and
mutated RNAs and of complexes s, f, C1 and C2 as described in
Figure 2 legend.
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sites, upstream (arrow a, lanes 3, 4, 8, 9) and downstream
(arrow b, lanes 3, 4, 8, 9) the PPT site. In order to evaluate
the sizes of truncated proteins we have targeted PO-ODNs
to the PPT and secondary sites in the presence of RNase H
(Figure 5C, lanes 5–7). These two additional products
were also observed with the shorter 9-mer, 9-mer-bis and
11-mer-bis PNAs (Figure 5C). It is noteworthy that
the translation arrests at these secondary sites were more
pronounced for the shorter PNAs, 9-mer and 9-mer-bis,
compared with the 13-mer-I PNA that appeared more
selective. PNA 13-mer-II that do not contain the T4CT4
sequence (see Table 1 for sequences) induces arrest
of translation only at PPT site (Figure 5C, lane 2).
Antisense activity on SLO-permeabilized cellsmediated
bytridecamer PNAs atsubmicromolar concentrations
By using the CMV (þ) PPT/HeLa cell line, containing
two reporter genes, the ﬁreﬂy luciferase gene (luc) and
the GFP gene, under the control of a bi-directional
doxycycline-inducible CMV promoter, we carried experi-
ments to study the intracellular antisense activity of
tridecamer PNAs that were shown as speciﬁc and eﬃcient
translation inhibitors in vitro. Two inserts containing
either the wild type HIV-1 PPT sequence or a mutated
sequence (HIV-2 PPT) were cloned in the 50 transcribed
region of the luciferase and GFP genes respectively
(Figure 6A). Therefore, it is an appropriate system to
test sequence-speciﬁc cellular activity of anti-PPT mole-
cules; PNAs targeted to the PPT sequence should induce
inhibition of luciferase expression without aﬀecting the
GFP expression (Figure 6A). The PNAs were introduced
into the cells by permeabilization of the cellular membrane
following treatment with SLO. The SLO-based protocol
is among the most eﬃcient methods, to eﬃciently deliver
oligonucleotides of various chemistries (17,18,26). A dose-
dependent speciﬁc inhibition of luciferase expression was
induced in the presence of PNA tridecamers in the
SLO-permeabilized cells (Figure 6 B). In these experi-
ments, an important fraction of cells ( 95%) was
permeabilized with an optimized amount of SLO without
inducing important cell mortality ( 20%). These param-
eters were measured using ﬂow cytometry analysis and
propidium iodide labelling of dead cells and ﬂuorescein
labelling of permeabilized cells. Fluorescent microscopy
studies without ﬁxation carried out after SLO-treatment
using ﬂuorescein-labelled tridecamer PNA has shown a
vesicular and nuclear localization of the PNA (data not
shown). Similar PNA intracellular distribution after SLO
permeabilization was observed using ﬁxed cells (26). At
1mM concentration, 13-mer-I and 13-mer-II PNA induced
a strong inhibition of luciferase expression ( 70%) with-
out aﬀecting GFP expression (Figure 6B). Treatment with
the control PNA containing a scrambled sequence
did not aﬀect luciferase activity (Figure 6B). Moreover,
tridecamer PNAs did not inhibit luciferase activity of
cells lacking the PPT insert (data not shown).
CONCLUSIONS
The interesting physicochemical properties and the in vitro
biological activity of T-rich and C-rich tridecamer
PNAs led us to test their intracellular antisense activity.
Uncharged PNAs cannot straightforward be admin-
istrated into living cells using cationic polymers or lipids
and the use of a DNA carrier is necessary to allow
complexation with cationic lipids; delivery of PNAs can be
also achieved by PNA attachment to cell-penetrating
peptides (CPP). Therefore, it is diﬃcult to make relevant
comparisons of cellular activity of PNAs (27–29). In order
to overcome this delivery problem we have used permea-
bilized cells; the SLO-based protocol is among the most
eﬃcient method existing at present, to eﬃciently deliver
oligonucleotides of various chemistries in cells (30).
Cellular experiments conﬁrmed the in vitro translation
experiments. The two tridecamer PNAs that form
at neutral pH very stable complexes, likely involving
duplex (13-mer-II) or triplex (13-mer-I) formation
with target PPT RNA, speciﬁcally inhibit translation in
SLO-permeabilized cells. In the present study, we show
that tridecamer PNAs are as eﬃcient as 18-mer phoshor-
amidate oligonucleotide, also administrated by a SLO
procedure (18), to act as antisense molecules by binding
to the complementary RNA target, present in the
50-untranslated region of a ﬁreﬂy luciferase reporter
gene. Moreover, while the phosphoramidate 18-mer,
complementary to the PPT sequence did not exhibit,
in vitro, any inhibitory eﬀect when targeted to the coding
portion of the mRNA, tridecamer PNAs very eﬃciently
arrested translation elongation with concomitant synthesis
of truncated peptide. Interestingly, this steric blockage of
translation elongation was not only observed with T-rich
triplex-forming PNAs as already described but also with
C-rich duplex-forming PNAs. Our results open new
perspectives for the development of such PNAs that can
be targeted to any RNA sequence, to produce intracellu-
larly truncated proteins of interest including dominant
negative versions.
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Figure 5. (A) (Left) Activity of diﬀerent PNAs (Table 1) on translation of HIV-1-integrase mRNA in a rabbit reticulocyte lysate. In vitro transcribed
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